PEAK6 Investments’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | $1.73K | Hold |
2
| – | – | ﹤0.01% | 828 |
|
2024
Q2 | $2.2K | Hold |
2
| – | – | ﹤0.01% | 884 |
|
2024
Q1 | $1.6K | Buy |
2
+1
| +100% | +$800 | ﹤0.01% | 912 |
|
2023
Q4 | $1.27K | Sell |
1
-2
| -67% | -$2.53K | ﹤0.01% | 1004 |
|
2023
Q3 | $2.29K | Buy |
3
+1
| +50% | +$763 | ﹤0.01% | 1001 |
|
2023
Q2 | $1.48K | Sell |
2
-1
| -33% | -$740 | ﹤0.01% | 922 |
|
2023
Q1 | $2.72K | Sell |
3
-454
| -99% | -$412K | ﹤0.01% | 1059 |
|
2022
Q4 | $330K | Buy |
457
+453
| +11,325% | +$327K | ﹤0.01% | 622 |
|
2022
Q3 | $2K | Sell |
4
-14,279
| -100% | -$7.14M | ﹤0.01% | 1465 |
|
2022
Q2 | $8.44M | Buy |
14,283
+14,281
| +714,050% | +$8.44M | 0.02% | 98 |
|
2022
Q1 | $1K | Sell |
2
-8,744
| -100% | -$4.37M | ﹤0.01% | 1612 |
|
2021
Q4 | $5.52M | Sell |
8,746
-2,124
| -20% | -$1.34M | 0.01% | 139 |
|
2021
Q3 | $6.58M | Buy |
10,870
+9,690
| +821% | +$5.86M | 0.01% | 161 |
|
2021
Q2 | $659K | Sell |
1,180
-25,169
| -96% | -$14.1M | ﹤0.01% | 796 |
|
2021
Q1 | $12.5M | Buy |
26,349
+24,647
| +1,448% | +$11.7M | 0.03% | 67 |
|
2020
Q4 | $822K | Buy |
+1,702
| New | +$822K | ﹤0.01% | 737 |
|
2020
Q3 | – | Hold |
0
| – | – | – | 1739 |
|
2020
Q2 | – | Hold |
0
| – | – | – | 1697 |
|
2020
Q1 | – | Hold |
0
| – | – | – | 1635 |
|
2019
Q4 | – | Sell |
-4,750
| Closed | -$1.32M | – | 1519 |
|
2019
Q3 | $1.32M | Sell |
4,750
-33,511
| -88% | -$9.3M | 0.01% | 356 |
|
2019
Q2 | $12M | Buy |
38,261
+33,447
| +695% | +$10.5M | 0.08% | 38 |
|
2019
Q1 | $1.98M | Sell |
4,814
-7,571
| -61% | -$3.11M | 0.01% | 257 |
|
2018
Q4 | $4.63M | Buy |
+12,385
| New | +$4.63M | 0.03% | 106 |
|
2018
Q3 | – | Hold |
0
| – | – | – | 1575 |
|